结构化生活方式项目对合并非酒精性脂肪性肝病的代谢综合征患者的影响
研究纳入2008至2016年完成密歇根大学代谢健康(MetFit)项目的403名成人,47.6%符合非酒精性脂肪性肝病(NAFLD)标准。项目结束时30%实现体重下降≥5%,NAFLD患者与非NAFLD患者的终点指标无差异,项目持续时间是应答的最重要预测因素。
要点
- 转诊至结构化生活方式项目的代谢综合征患者中近半数合并NAFLD。
- NAFLD患者基线代谢紊乱更明显,但项目在减重和代谢综合征组分缓解上同样有效。
- 项目持续时间(OR 6.7,95%CI 3.6-12.3)是≥5%体重下降的独立预测因素。
核心结论
- 转诊至结构化生活方式项目的代谢综合征患者中近半数合并NAFLD,尽管NAFLD患者基线代谢紊乱更明显,该项目在实现体重下降和缓解代谢综合征组分方面同样有效,项目持续时间是应答的最重要预测因素。
研究设计与样本
- 纳入2008年至2016年间完成密歇根大学代谢健康(MetFit)项目的成人,共403例(12周253例,24周150例),在入组时及第12周和第24周收集临床和实验室数据,NAFLD基于肝活检、影像或临床诊断定义。
主要发现
- 队列以中年(中位54岁)、白人(88%)、男性(63%)、重度肥胖(中位BMI 37.4)为主,47.6%符合NAFLD标准。
- 基线时NAFLD患者较非NAFLD患者更年轻(52岁 vs 55岁),体重更高,代谢紊乱更多(空腹胰岛素和甘油三酯更高,高密度脂蛋白胆固醇更低)。
- 项目完成时,30%实现体重下降≥5%,62%高甘油三酯血症缓解,33%低HDL缓解,27%空腹血糖受损缓解,43%丙氨酸氨基转移酶正常化。
- 终点指标不受NAFLD影响。
- 项目持续时间(OR 6.7,95%CI 3.6-12.3)和白人种族(OR 3.83,95%CI 1.04-1.76)是≥5%体重下降的独立预测因素。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Lifestyle interventions are first-line therapy for non-alcoholic fatty liver disease (NAFLD). AIMS: To examine the prevalence of NAFLD among participants of the University of Michigan Metabolic Fitness (MetFit) Programme and to assess the impact of this programme on weight, metabolic and liver-related parameters among patients with and without NAFLD. METHODS: Adults who completed the programme between 2008 and 2016 were included. Clinical and laboratory data were collected at enrolment, and at 12 and 24 weeks. NAFLD was defined based on liver biopsy, imaging or clinical diagnosis. RESULTS: The cohort (N = 403; 253 12-week, 150 24-week) consisted primarily of middle-aged (median 54 years) white (88%) men (63%) with severe obesity (median BMI 37.4). 47.6% met criteria for NAFLD. At baseline, NAFLD patients were younger (52 vs 55 years), had higher weights and more metabolic derangements (higher fasting insulin and triglyceride, lower high-density lipoprotein-cholesterol). At programme completion, 30% achieved weight reduction ≥5%, 62% resolution of hypertriglyceridaemia, 33% resolution of low HDL, 27% resolution of impaired fasting glucose and 43% normalisation of alanine aminotransferase. Endpoints were unaffected by NAFLD. Longer programme duration (OR 6.7, 95% CI 3.6-12.3) and white race (OR 3.83, 95% CI 1.04-1.76) were independent predictors of ≥5% weight loss. CONCLUSIONS: Nearly half of the patients referred to a structured lifestyle programme for metabolic syndrome had NAFLD. Although baseline metabolic derangements were more pronounced among NAFLD patients, the programme was equally efficacious in achieving weight loss and resolving metabolic syndrome components. Programme duration was the most important predictor of response.
引用
- Konerman MA, Walden P, Joseph M, et al. Impact of a structured lifestyle programme on patients with metabolic syndrome complicated by non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2018. PMID: 30561027. doi:10.1111/apt.15063
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。